Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer

Abstract Pancreatic ductal adenocarcinoma (PDAC) responds poorly to systemic treatment, including new immunotherapeutic approaches. Biomarkers are urgently needed for early disease detection, patient stratification for treatment, and response prediction. The role of soluble CD40 (sCD40) is unknown i...

詳細記述

書誌詳細

出版年:	npj Precision Oncology
主要な著者:	David Digomann, Max Heiduk, Charlotte Reiche, Jessica Glück, Christoph Kahlert, Peter Mirtschink, Anna Klimova, Florian Bösch, Torsten Tonn, Jochen Gaedcke, Michael Ghadimi, Jürgen Weitz, Lena Seifert, Adrian M. Seifert
フォーマット:	論文
言語:	英語
出版事項:	Nature Portfolio 2023-10-01
オンライン･アクセス:	https://doi.org/10.1038/s41698-023-00459-9